110 related articles for article (PubMed ID: 20597007)
21. Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea.
Heimesaat MM; Granzow K; Leidinger H; Liesenfeld O
Infection; 2005 Oct; 33(5-6):340-4. PubMed ID: 16258864
[TBL] [Abstract][Full Text] [Related]
22. Epithelial cell I kappa B-kinase beta has an important protective role in Clostridium difficile toxin A-induced mucosal injury.
Chae S; Eckmann L; Miyamoto Y; Pothoulakis C; Karin M; Kagnoff MF
J Immunol; 2006 Jul; 177(2):1214-20. PubMed ID: 16818780
[TBL] [Abstract][Full Text] [Related]
23. Clostridium difficile and the disease it causes.
Norén T
Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
[TBL] [Abstract][Full Text] [Related]
24. Toxin A-negative, toxin B-positive Clostridium difficile.
Drudy D; Fanning S; Kyne L
Int J Infect Dis; 2007 Jan; 11(1):5-10. PubMed ID: 16857405
[TBL] [Abstract][Full Text] [Related]
25. Correlation of the detection of Clostridium difficile toxins in stools and presence of the clostridia in tissues of children.
Guarner J; Bhatnagar J; Shane AL; Jones T; DeLeon-Carnes MN; Schemankewitz E; Zaki SR
Hum Pathol; 2010 Nov; 41(11):1586-92. PubMed ID: 20656321
[TBL] [Abstract][Full Text] [Related]
26. Cloning and expression of Clostridium difficile toxin A gene (tcdA) by PCR amplification and use of an expression vector.
Ackermann G; Löffler B; Tang-Feldman YJ; Cohen SH; Silva J; Rodloff AC
Mol Cell Probes; 2004 Aug; 18(4):271-4. PubMed ID: 15271388
[TBL] [Abstract][Full Text] [Related]
27. Clostridium difficile toxins may augment bacterial penetration of intestinal epithelium.
Feltis BA; Kim AS; Kinneberg KM; Lyerly DL; Wilkins TD; Erlandsen SL; Wells CL
Arch Surg; 1999 Nov; 134(11):1235-41; discussion 1241-2. PubMed ID: 10555639
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of different methods for detection of Clostridium difficile toxins in Poland.
Martirosian G; Pituch H; Obuch-Woszczatyński P; Rouyan G; Meisel-Mikołajczyk F
Acta Microbiol Pol; 1999; 48(4):349-53. PubMed ID: 10756719
[TBL] [Abstract][Full Text] [Related]
29. Clostridium difficile toxins facilitate bacterial colonization by modulating the fence and gate function of colonic epithelium.
Kasendra M; Barrile R; Leuzzi R; Soriani M
J Infect Dis; 2014 Apr; 209(7):1095-104. PubMed ID: 24273043
[TBL] [Abstract][Full Text] [Related]
30. Isolation and characterisation of toxin A-negative, toxin B-positive Clostridium difficile in Dublin, Ireland.
Drudy D; Harnedy N; Fanning S; O'Mahony R; Kyne L
Clin Microbiol Infect; 2007 Mar; 13(3):298-304. PubMed ID: 17391385
[TBL] [Abstract][Full Text] [Related]
31. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
[TBL] [Abstract][Full Text] [Related]
32. Clostridium difficile infection in patients with ileal pouch-anal anastomosis.
Shen BO; Jiang ZD; Fazio VW; Remzi FH; Rodriguez L; Bennett AE; Lopez R; Queener E; Dupont HL
Clin Gastroenterol Hepatol; 2008 Jul; 6(7):782-8. PubMed ID: 18467184
[TBL] [Abstract][Full Text] [Related]
33. Lack of value of repeat stool testing for Clostridium difficile toxin.
Mohan SS; McDermott BP; Parchuri S; Cunha BA
Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
[TBL] [Abstract][Full Text] [Related]
34. New trends in Clostridium difficile virulence and pathogenesis.
Denève C; Janoir C; Poilane I; Fantinato C; Collignon A
Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S24-8. PubMed ID: 19303565
[TBL] [Abstract][Full Text] [Related]
35. Systemically administered IgG anti-toxin antibodies protect the colonic mucosa during infection with Clostridium difficile in the piglet model.
Cohen OR; Steele JA; Zhang Q; Schmidt DJ; Wang Y; Hamel PE; Beamer G; Xu B; Tzipori S
PLoS One; 2014; 9(10):e111075. PubMed ID: 25347821
[TBL] [Abstract][Full Text] [Related]
36. Effects of Clostridium difficile toxins on epithelial cell barrier.
Pothoulakis C
Ann N Y Acad Sci; 2000; 915():347-56. PubMed ID: 11193598
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric analysis of Clostridium difficile adherence to human intestinal epithelial cells.
Drudy D; O'Donoghue DP; Baird A; Fenelon L; O'Farrelly C
J Med Microbiol; 2001 Jun; 50(6):526-534. PubMed ID: 11393290
[TBL] [Abstract][Full Text] [Related]
38. Clostridium difficile-mediated effects on human intestinal epithelia: Modelling host-pathogen interactions in a vertical diffusion chamber.
Jafari NV; Kuehne SA; Minton NP; Allan E; Bajaj-Elliott M
Anaerobe; 2016 Feb; 37():96-102. PubMed ID: 26708704
[TBL] [Abstract][Full Text] [Related]
39. Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.
Qamar A; Aboudola S; Warny M; Michetti P; Pothoulakis C; LaMont JT; Kelly CP
Infect Immun; 2001 Apr; 69(4):2762-5. PubMed ID: 11254650
[TBL] [Abstract][Full Text] [Related]
40. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment.
Mahida YR; Makh S; Hyde S; Gray T; Borriello SP
Gut; 1996 Mar; 38(3):337-47. PubMed ID: 8675084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
